CURRENT OPINION IN PHARMACOLOGY

简称 CURR OPIN PHARMACOL ·ENGLAND ·出版周期 Bimonthly ·年均收录 95 篇

4.2

最新影响因子

2.60%

自引率

一般

投稿难度

偏慢,4-8周

审稿周期

期刊简介

CURRENT OPINION IN PHARMACOLOGY是一本国际知名的药理学杂志，ISSN号为1471-4892，由Elsevier出版社出版，出版地为英国，出版周期为双月刊。该杂志的影响因子较高，具体数值每年有所波动，属于SCI收录期刊，并且在中科院分区中通常位于药理学领域的较高分区。杂志为非开放获取（非OA）期刊。其发文特点侧重于药理学领域的最新研究进展和综述文章，涵盖药物发现、药效学、药代动力学、毒理学以及临床药理学等多个研究方向，旨在为读者提供权威且前沿的学术观点。杂志的质量较高，审稿严格，但作为综述类期刊，其原创性研究较少，可能不适合以发表实验性研究为主的学者。投稿风险较低，但接受率相对有限，适合领域内资深研究者投稿。

影响因子趋势

近期发表

Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk 2026-08-13

Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potential 2026-08-10

Mechanistic anticancer effects of melittin across cancer hallmarks: A narrative evidence synthesis 2026-08-07

Mitochondria as a therapeutic platform in inflammatory and degenerative disorders: mechanisms, biomarkers, and translational challenges 2026-08-08

Editorial: Central and peripheral nervous system 2026-07-06

The vasopressin system as an immunoneuroendocrine therapeutic target in inflammatory conditions 2026-08-10

Clinical pharmacokinetics of afatinib: A systematic review 2026-07-08

Editorial Board 2026-09-08

Pharmacological basis of Edaravone–Dexborneol neuroprotection: Integrated modulation of oxidative stress, neuroinflammation, and ferroptosis 2026-08-07

Pharmacological targeting of neuroimmune–synaptic interactions in Alzheimer's disease: Integrating NETosis, microglia, and synaptic vulnerability 2026-07-20